LifeStance Health GroupLFST +3.58%56 Return-on-Tangible-Asset is 8.10% as of Mar. 2026. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.23 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, LifeStance Health Group ranks better than 54.61% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. LifeStance Health Group's annualizedNet Income for the quarter that ended in Mar. 2026 was $57 Mil. LifeStance Health Group's average total tangible assets for the quarter that ended in Mar. 2026 was $703 Mil. Therefore, LifeStance Health Group's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 8.10%.
The historical rank and industry rank for LifeStance Health Group's Return-on-Tangible-Asset or its related term are showing as below:
LFST'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -109.62 Med: -19.78 Max: 11.07
Current: 3.44
During the past 7 years, LifeStance Health Group's highest Return-on-Tangible-Asset was 11.07%. The lowest was -109.62%. And the median was -19.78%.
LFST's Return-on-Tangible-Asset is ranked better than 54.61% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 2.43
vs LFST: 3.44
LifeStance Health Group (NAS:LFST) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
LifeStance Health Group Return-on-Tangible-Asset Related Terms
LifeStance Health Group Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for LifeStance Health Group's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group Return-on-Tangible-Asset Chart
LFST vs CON, BKD, OPCH: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 8.10% mean?
LifeStance Health Group (LFST) has a Return-on-Tangible-Asset of 8.10% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on LifeStance Health Group and its competitors. According to the industry distribution chart, LifeStance Health Group ranks #310 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 45.4%.
Is LifeStance Health Group's Return-on-Tangible-Asset too high?
LifeStance Health Group's current Return-on-Tangible-Asset is 8.10%. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.43. LifeStance Health Group's value of 8.10% is 233.3% above this industry median. Based on the distribution chart, LifeStance Health Group ranks #310 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Return-on-Tangible-Asset compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #310 out of 683 companies for Return-on-Tangible-Asset. This puts LifeStance Health Group in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.43. LifeStance Health Group's value of 8.10% is 233.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Return-on-Tangible-Asset of 8.10% is 233.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Return-on-Tangible-Asset is 8.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.23, compared to a current price of $10.72 — trading 30.3% above its estimated fair value. The current Return-on-Tangible-Asset is 8.10% and 233.3% above the Healthcare Providers & Services industry median of 2.43. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Return-on-Tangible-Asset is 8.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.72 is trading 30.3% above its estimated GF Value™ of $8.23.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
Return-on-Tangible-Asset: 8.10%
GF Value™: $8.23 vs. price of $10.72 (30.3% above fair value)
Industry Position: 233.3% above the Healthcare Providers & Services median (#310 of 683)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
